MedPath

Guaifenesin 600 mg

Drug Facts

Approved
Approval ID

525fda90-134c-f038-c403-eb5ffc1fb1f1

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Sep 22, 2025

Manufacturers
FDA

Dr. Reddy's Laboratories Inc.

DUNS: 802315887

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Guaifenesin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-108
Application NumberANDA215932
Product Classification
M
Marketing Category
C73584
G
Generic Name
Guaifenesin
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 22, 2025
FDA Product Classification

INGREDIENTS (10)

GuaifenesinActive
Quantity: 1200 mg in 1 1
Code: 495W7451VQ
Classification: ACTIB
Carbomer Homopolymer Type B (Allyl Pentaerythritol Crosslinked)Inactive
Code: HHT01ZNK31
Classification: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Ferric Oxide RedInactive
Code: 1K09F3G675
Classification: IACT
Hydroxypropyl Cellulose (110000 Wamw)Inactive
Code: 5Y0974F5PW
Classification: IACT
Hypromellose 2910 (10000 Mpa.S)Inactive
Code: 0HO1H52958
Classification: IACT
Hypromellose 2208 (4000 Mpa.S)Inactive
Code: 39J80LT57T
Classification: IACT
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Microcrystalline CelluloseInactive
Code: OP1R32D61U
Classification: IACT
Sodium Starch Glycolate Type A PotatoInactive
Code: 5856J3G2A2
Classification: IACT

Guaifenesin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-110
Application NumberANDA215932
Product Classification
M
Marketing Category
C73584
G
Generic Name
Guaifenesin
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 22, 2025
FDA Product Classification

INGREDIENTS (10)

GuaifenesinActive
Quantity: 600 mg in 1 1
Code: 495W7451VQ
Classification: ACTIB
Carbomer Homopolymer Type B (Allyl Pentaerythritol Crosslinked)Inactive
Code: HHT01ZNK31
Classification: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Ferric Oxide RedInactive
Code: 1K09F3G675
Classification: IACT
Hydroxypropyl Cellulose (110000 Wamw)Inactive
Code: 5Y0974F5PW
Classification: IACT
Hypromellose 2910 (10000 Mpa.S)Inactive
Code: 0HO1H52958
Classification: IACT
Hypromellose 2208 (4000 Mpa.S)Inactive
Code: 39J80LT57T
Classification: IACT
Magnesium StearateInactive
Code: 70097M6I30
Classification: IACT
Microcrystalline CelluloseInactive
Code: OP1R32D61U
Classification: IACT
Sodium Starch Glycolate Type A PotatoInactive
Code: 5856J3G2A2
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 7/31/2021

Principal Display Panel - 1200 mg Carton

Guaifenesin Extended-Release Tablets****1200 mg Carton Label

1200mg carton

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 7/31/2021

Use(s)

  • helps loosen phlegum (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 7/31/2021

Active ingredient(s)

Guaifenesin 600 mg (for 600mg)

Guaifenesin 1200 mg (for 1200 mg)

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 7/31/2021

Purpose

Expectorant

WARNINGS SECTION

LOINC: 34071-1Updated: 7/31/2021

Warnings

Applicable warning(s) in 201.66(c)(5)(i) and (ii)

Do not use

  • For children under 12 years age

Ask a doctor before use if

  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema

  • cough accompanied by too much phlegm (mucus)

Stop use and ask doctor if

  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If Pregnancy/Breastfeeding,

ask a health professional before use.

Keep out of reach of children

In case of overdose, get medical help or contact aPoison Control Center right away (1-800-222-1222).

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 7/31/2021

Directions

  • do not crush, chew, or break tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours (for 600 mg)
  • adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours (for 1200 mg)
  • children under 12 years of age: do not use

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 7/31/2021

Distributed by:

Dr. Reddy’s Laboratories, Inc.

Princeton, NJ 08540

Made in India

I 0721

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 7/31/2021

Inactive ingredients

carbomer homopolymer type B, colloidal silicon dioxide, ferric oxide red, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A

OTC - QUESTIONS SECTION

LOINC: 53413-1Updated: 7/31/2021

Questions?

call** 1-888-375-3784** Weekdays (8am - 8pm EST)

You may also report side effects to this phone number.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.